Increased serum insulin associated with increased risk of prostate cancer recurrenceSteven Lehrer
Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA
Prostate 50:1-3. 2002
..Also, new prostate cancer therapies might be directed toward inhibiting the mitogenic effects of insulin...
Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factorSteven Lehrer
Department of Radiation Oncology, Mount Sinai School of Medicine, Box 1236, NY 10029, USA
Med Hypotheses 78:657-8. 2012
..If so, glioblastoma multiforme occurrence would resemble paralytic polio, where low socioeconomic status, poor hygiene and early infection are protective...
No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and HispanicsSteven Lehrer
Department of Radiation Oncology, Mount Sinai Medical Center Box 1236, New York 10029, USA
Anticancer Res 32:1113-5. 2012
..However, another study reported that five glioblastoma patients showed no circulating CMV detected either with RT-PCR or blood culture...
Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jawsSteven Lehrer
Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:389-91. 2008
..This anatomic concentration of bisphosphonates might cause bisphosphonate-osteonecrosis to be manifested exclusively in the jaws and is consistent with our finding of normal serum bone markers in ONJ patients...
Anopheles mosquito transmission of brain tumorSteven Lehrer
Med Hypotheses 74:167-8. 2010
..If a mosquito-transmitted brain tumor virus could be identified, development of a brain tumor vaccine might be possible...
Serum thyroid-stimulating hormone is elevated in men with Gleason 8 prostate cancerSteven Lehrer
Department of Radiation Oncology, Mount Sinai Medical Center, Bronx, New York, NY 10029, USA
BJU Int 96:328-9. 2005
....
C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancerSteven Lehrer
Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY 10029, USA
BJU Int 95:961-2. 2005
....
Association between malaria incidence and all cancer mortality in fifty U.S. States and the District of ColumbiaSteven Lehrer
Associate Professor Radiation Oncology, Mount Sinai School of Medicine, New York, New York 10023, USA
Anticancer Res 30:1371-3. 2010
....
Prostate cancer in a large prostate is associated with a decreased prostate specific antigen failure rate after brachytherapySteven Lehrer
Department of Radiation Oncology and Urology, Mount Sinai Medical Center, 1 Gustave L Levy Place, New York, NY 10029, USA
J Urol 173:79-81. 2005
..In the current study we analyzed the relationship of prostate size and prostate specific antigen (PSA) failure in men undergoing brachytherapy for localized prostate cancer...
Putative protein markers in the sera of men with prostatic neoplasmsS Lehrer
Departments of Radiation Oncology, Medicine, and Urology, Mount Sinai School of Medicine, New York 10029, USA
BJU Int 92:223-5. 2003
..To describe the preliminary identification of serum proteins that may be diagnostic markers in prostate cancer...
Association between number of cell phone contracts and brain tumor incidence in nineteen U.S. StatesSteven Lehrer
Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA
J Neurooncol 101:505-7. 2011
..In the meantime, it would be prudent to limit exposure to all sources of electro-magnetic radiation...
No circulating cytomegalovirus in five patients with glioblastoma multiformeSteven Lehrer
Mount Sinai Medical Center, Box 1236, New York 10029, USA
Anticancer Res 31:959-60. 2011
....
Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancerS Lehrer
Department of Radiation Oncology, Mount Sinai School of Medicine, New York and the Veterans Affairs Medical Center, Bronx, New York, NY 10029, USA
Br J Cancer 87:726-8. 2002
..Further studies may document whether serum insulin levels might be a useful biomarker of prostate cancer stage...
Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate geneSteven Lehrer
Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA
J Oral Maxillofac Surg 67:159-61. 2009
..To determine whether any abnormality in serum bone markers is related to bisphosphonate-induced osteonecrosis of the jaw...
Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancerS Lehrer
Department of Radiation Oncology, Mount Sinai School of Medicine, New York, New York 10029, USA
Br J Cancer 78:771-3. 1998
..05, two-tailed Fisher's exact test). The contribution of germline BRCA1 and BRCA2 mutations to prostate cancer incidence is probably small and could be limited to specific subgroups...
Reverse transcriptase-polymerase chain reaction for prostate-specific antigen may be a prognostic indicator in breast cancerS Lehrer
Department of Radiation Oncology, Mount Sinai Medical Center, New York, USA
Br J Cancer 74:871-3. 1996
....
Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasiaSteven Lehrer
Department of Radiation Oncology, Mount Sinai School of Medicine and Veterans Affairs Medical Center, The Bronx, New York, USA
J Urol 168:2431-3. 2002
..Triiodothyronine may be such a biomarker. Also, new prostate cancer and BPH therapies may be directed toward inhibiting the mitogenic effects of triiodothyronine...
Association of an estrogen receptor variant with increased height in womenS Lehrer
Departments of Radiation Oncology, Mount Sinai School of Medicine, New York
Horm Metab Res 26:486-8. 1994
..This second mutation might lie within the estrogen receptor itself or within one of the genes nearby...
Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantationSteven Lehrer
Department of Radiation Oncology, Mount Sinai Medical Center, New York 10029, USA
BJU Int 98:979-81. 2006
..g. terazosin, combined with sildenafil, might be of benefit. Also, patients with a high IPSS before brachytherapy can be warned that they have a greater risk of flare and ED...
ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancerJamie A Cesaretti
Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA
Int J Radiat Oncol Biol Phys 61:196-202. 2005
....
Elevated serum triiodothyronine (t3) in Ashkenazi Jewish prostate cancer patients carrying the I1307k allele of the APC (adenopolyposis coli) geneSteven Lehrer
Department of Radiation Oncology, Mount Sinai School of Medicine, New York, New York, USA
Urol Oncol 21:101-4. 2003
..0, P = 0.14). Also, there is an association of APC mutations with thyroid cancer. In this study, we measured triiodothyronine (t3) levels in Ashkenazi Jewish prostate cancer patients, with and without the I1307K mutation of the APC gene...
Association between American Urologic Association (AUA) urinary symptom score and disease stage in men with localized prostate cancerSteven Lehrer
Department of Radiation Oncology and Urology, Mount Sinai School of Medicine, New York, NY, USA
Urol Oncol 7:73-6. 2002
..Further studies of AUA symptom score and outcome would be worthwhile. If AUA symptom score is a predictor of outcome that is independent of t stage, AUA score might be clinically valuable in disease management...
Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancerSteven Lehrer
J Natl Cancer Inst 94:1893; author reply 1893-4. 2002